Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Ruxolitinib can cause a delayed skin reaction on the nose.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Fat cells help recruit healing cells and build skin structure during wound healing.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Potassium channel openers like minoxidil help hair grow by acting on hair follicles.

Immune cells affect hair growth and could lead to new hair loss treatments.

Trichotillomania is a chronic condition where people uncontrollably pull out their hair, often starting in childhood.

Trichotillomania treatment is most successful with a mix of behavioral therapy, medication, and social support.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

An 11-year-old girl with Trichotillomania developed a large hairball in her stomach, treated with medication, therapy, and family education.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The diphosphonate was the most effective at preventing calcification in rats.